Boulos, J., Saeed, M., Chatterjee, M., Bülbül, Y., Crudo, F., Marko, D., . . . Efferth, T. (2021). Repurposing of the ALK inhibitor crizotinib for acute leukemia and multiple myeloma cells. Pharmaceuticals, 14(11), . https://doi.org/10.3390/ph14111126
Chicago-Zitierstil (17. Ausg.)Boulos, Joelle, Mohamed Saeed, Manik Chatterjee, Yagmur Bülbül, Francesco Crudo, Doris Marko, Markus Munder, Sabine Klauck, und Thomas Efferth. "Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells." Pharmaceuticals 14, no. 11 (2021). https://doi.org/10.3390/ph14111126.
MLA-Zitierstil (9. Ausg.)Boulos, Joelle, et al. "Repurposing of the ALK Inhibitor Crizotinib for Acute Leukemia and Multiple Myeloma Cells." Pharmaceuticals, vol. 14, no. 11, 2021, https://doi.org/10.3390/ph14111126.